Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Partial Epilepsy”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)Study completedNCT00871377
What this trial is testing

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures

Who this might be right for
Epilepsy
National Center for Complementary and Integrative Health (NCCIH) 24
Post-approval studies (Phase 4)UnknownNCT02726919
What this trial is testing

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Who this might be right for
Epilepsy
Pavel Klein 20
Not applicableEnded earlyNCT00382707
What this trial is testing

Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.

Who this might be right for
Refractory Frontal Lobe Epilepsy
University Hospital, Strasbourg, France 15
Not applicableStudy completedNCT03533530
What this trial is testing

Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy

Who this might be right for
ElectroencephalographyRefractory EpilepsyBrain Imaging+1 more
Rigshospitalet, Denmark 82
Not applicableLooking for participantsNCT03644732
What this trial is testing

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

Who this might be right for
Refractory EpilepsyFocal Epilepsy
University Hospital, Grenoble 200
Large-scale testing (Phase 3)Study completedNCT00957684
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Refractory Partial Epilepsy
Bial - Portela C S.A. 402
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Not applicableStudy completedNCT00071305
What this trial is testing

Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 35
Testing effectiveness (Phase 2)Study completedNCT02170064
What this trial is testing

Pharmacokinetics, Efficacy and Tolerability of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 35
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableUnknownNCT04383028
What this trial is testing

MELD as an Adjunct for SEEG Trajectories

Who this might be right for
EpilepsyEpilepsy, FocalEpilepsy, Refractory
Great Ormond Street Hospital for Children NHS Foundation Trust 20
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Not applicableActive Not RecruitingNCT06681480
What this trial is testing

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Who this might be right for
Focal EpilepsyTranscranial Magnetis Stimulation
Comenius University 20
Testing effectiveness (Phase 2)Study completedNCT00141414
What this trial is testing

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Who this might be right for
Epilepsy, Partial
Pfizer 82
Early research (Phase 1)Study completedNCT02264652
What this trial is testing

High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy

Who this might be right for
Epilepsy
NYU Langone Health 1
Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Not applicableNot Yet RecruitingNCT07399327
What this trial is testing

Biomarkers of Response to SEEG Thermocoagulation

Who this might be right for
Drug Resistant Epilepsy
Assistance Publique Hopitaux De Marseille 45
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Large-scale testing (Phase 3)Study completedNCT00334958
What this trial is testing

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 356
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Load More Results